Skip to main content

What the FDA labels say about taking them together

Aprepitant and midazolam

Aprepitant's FDA label of July 5, 2024 names midazolam in its drug interactions section; the midazolam labels PlainMeds reads (4) do not name aprepitant. The aprepitant label: “Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions.”

Check it at the source: the aprepitant FDA label on DailyMed (effective July 5, 2024, Merck Sharp & Dohme LLC); the midazolam FDA label on DailyMed (effective January 1, 2024, Fresenius Kabi USA, LLC).

What does the aprepitant label say about midazolam?

Aprepitant label, drug interactions

Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions [see ].

Source: FDA drug label (EMEND), NDA021549 (Msd), as published by Merck Sharp & Dohme LLC, effective July 5, 2024 (SPL set 696f9e80-9cae-403b-de9e-078343ce4713), via openFDA; the full label on DailyMed

What does the midazolam label say about aprepitant?

Midazolam's label (effective January 1, 2024) and its 3 other brand-application labels do not name aprepitant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Midazolam), Fresenius Kabi USA, LLC, effective January 1, 2024 (SPL set 1cc9ba6e-fa1b-405e-9de8-720c567b2a73), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Aprepitant generic labelers
22Midazolam generic labelers
AprepitantMidazolam
Labeled forNausea and vomitingn/a
Boxed warningNoYes
Pharmacy cost (NADAC)$46.42 per capsule 40 mg capsule$0.233 per mL 2 mg/2 mL vial
Shortage nowA presentation being discontinuedIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?